Results 171 to 180 of about 19,810 (202)

Efficacy and Safety of Dolutegravir With Emtricitabine and Tenofovir Alafenamide Fumarate or Tenofovir Disoproxil Fumarate, and Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate HIV Antiretroviral Therapy Regimens Started in Pregnancy (IMPAACT 2010/VESTED): A Multicentre, Open-Label, Randomised, Controlled, Phase 3 Trial

Lancet, The, 2021
Lee Fairlie, Paul E Sax, Lisa M Frenkel
exaly  

Tenofovir Alafenamide for Drug-Resistant Hepatitis B: A Randomized Trial for Switching From Tenofovir Disoproxil Fumarate

Clinical Gastroenterology and Hepatology, 2022
Yoon Jun Kim, Byung-Chul Yoo, Young-Suk Lim   +2 more
exaly  

Not all is perfect with Tenofovir alafenamide

HIV Medicine, 2019
S Noe, C Jonsson‐Oldenbuettel, H Jaeger   +2 more
openaire   +2 more sources

Antineoplastics/tenofovir-alafenamide

Reactions Weekly, 2022
openaire   +1 more source

Emtricitabine and Tenofovir Alafenamide vs Emtricitabine and Tenofovir Disoproxil Fumarate for HIV Pre-Exposure Prophylaxis (DISCOVER): Primary Results From a Randomised, Double-Blind, Multicentre, Active-Controlled, Phase 3, Non-Inferiority Trial

Lancet, The, 2020
Moupali Das, Kenneth Hugh Mayer, Robert T. Grant   +2 more
exaly  

Tenofovir alafenamide

Reactions Weekly, 2019
openaire   +1 more source

Efficacy and Safety of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in Treatment-Naïve Chronic Hepatitis B

Liver International, 2022
Young-Suk Lim, Jihye Lim, Kang Mo Kim
exaly  

Tenofovir-alafenamide withdrawal

Reactions Weekly, 2022
openaire   +1 more source

Entecavir/tenofovir-alafenamide

Reactions Weekly, 2023
openaire   +1 more source

Doxorubicin/tenofovir-alafenamide

Reactions Weekly, 2022
openaire   +1 more source